Up for a little learning during your lunch break? There will be several informative seminars provided by industry. Grab a free lunch and hear leaders in the neurosurgical field present during these sessions. These are non-CME events.
Monday, April 24, 2017
Advanced Techniques in Achieving Integrated Spinal Alignment
Faculty: Regis W. Haid Jr., MD, FAANS; Christopher I. Shaffrey, MD, FAANS; Juan Uribe, MD, FAANS
Achieving spinal alignment has been shown to correlate with long term successful clinical outcomes. However, as patients and pathologies vary greatly, so can the many ways to approach complex alignment challenges. Join us as we take a case-based look at advanced techniques to achieve your spinal alignment goals through multiple approaches and the use of some of the latest computer-assisted technology.
Presented by NuVasive, Inc.
How Expandable Technology Has Changed My Practice
Faculty: Nicholas Theodore, MD, FAANS
Expandable implants have made a profound impact on surgeons looking to minimize impaction and restore disc height. Learn from surgeons who have experienced the benefits of expandable technology.
Presented by Globus Medical
Novalis Circle Symposium: Technology Developments for Primary Brain Tumors
Meet world-renowned clinicians who will present the latest technologies in surgical and radiosurgical treatment of primary brain tumors.
Presented by Brainlab
PRESTIGE LP™ Cervical Disc Adjacent Two-Level Arthroplasty: Design Rationale, Surgical Technique, and 7-year Data
Faculty: Dr. Vincent Traynelis
Attendees of this workshop will gain a full appreciation of the PRESTIGE LP™ 2-level indications, including the clinical data that supported this approval. Additionally, our distinguished faculty will review the PRESTIGE LP™ implant design and surgical technique, including patient selection, anatomical considerations, and appropriate strategies to avoid and manage surgical complications.
Presented by Medtronic
Skull Base Microsurgery in the Era of Endoscopy
Faculty: Daniel Prevedello, MD
Presented by Codman Neuro
Tritanium®: A Novel Highly Porous Titanium Alloy for Interbody Fusion Procedures
Faculty: Matthew J. McGirt, MD, FAANS
Stryker's proprietary Tritanium In-Growth Technology is inspired by the microstructure of cancellous bone and enabled by Stryker's patent-protected 3D additive manufacturing process. This material is designed to promote long-term stability through bone in-growth and biological fixation. 1 While the Tritanium PL Cage was the first spinal implant manufactured using this unique technology, Stryker's Spine division is excited to expand the use of Tritanium across its interbody device portfolio over the next few years.
- Tritanium technology claim support memo, PROJ 43909
Presented by Stryker
Tuesday, April 25, 2017
Deep Brain Stimulation: Combining Speed and Precision
Faculty: Doroata Tassigny, MD
Due to improvement in image fusion capabilities of the Hybrid OR and in MRI imaging combined with the possibility of intraoperative control of lead position using the Artis Zeego, our DBS procedure is now performed under general anesthesia without moving the patient. Our results are comparable to those in the literature in terms of improvement in UPDRS scores. The significant decrease of the surgical procedure time may lead to a reduced rate of complications.
Presented by Siemens Healthineers
Minimally Invasive Sacroiliac Joint Fusion, Radiofrequency Denervation and Conservative Management for Sacroiliac Joint Pain: Six Year Comparative Study
Faculty: Vicente Vanaclocha, MD, PhD
Studies show that up to 25% of chronic low back pain is sacroiliac joint in origin and that the diagnosis of sacroiliac joint disease is frequently overlooked by physicians. Learn about the latest long-term results comparing non-surgical treatment options to SI joint fusion with the iFuse Implant System. The iFuse Implant System is a minimally invasive sacroiliac implant system for SI joint dysfunction caused by SI joint disruption and degenerative sacroiliitis.
Presented by SI-BONE, Inc.
Spinal Cord Stimulation - High Dose? Low Dose? Apply the Right Dose for the Right Patient
Faculty: Amr O. El-Naggar, MD, FAANS; Steven Falowski, MD, FAANS
Spinal cord stimulation (SCS) has seen an influx of high energy options. Join us for lunch and insight into SCS systems - what they offer and how they differ. This symposium will provide insight into high dose and sensor driven low dose stimulation. In addition, you'll hear the latest on MR imaging of patients with implanted SCS systems.
Presented by Medtronic
The New Direction for Deep Brain Stimulation: How Directional Lead Design Can Impact Clinical Practice
Faculty: Brian H. Kopell, MD, FAANS; Paul S. Larson, MD, FAANS; Jan Vesper, MD, PhD
This workshop will discuss the advantages and disadvantages of directional and traditional lead technology for the treatment of Parkinson’s disease and Essential Tremor. Participants will compare scenarios where the directional lead can offset sub-optimally placed electrodes and determine the effect directional leads can have on optimally placed electrodes. Distinguished faculty will review recent evidence for constant current in patients on either stable or waning therapy.
Presented by Abbott
What is the Next Evolution of Multi-Modality Imaging and Robotics in Neurosurgery?
Faculty: Joshua B. Bederson, MD, FAANS; Costas G. Hadjipanayis, MD, PhD, FAANS; Michael Lawton, MD, FAANS; Peter Nakaji, MD, FAANS
What is the evolution of neurosurgical multi-modal imaging and its role in surgical workflows? This symposium will address how the advent of multimodality imaging technology, including advanced neuro-exploration tools* and visualization methods may impact neurosurgical outcomes.
*The discussion may include information on products and features that are a work in progress, may require FDA 510(k) clearance and are subject to change. Future availability cannot be guaranteed.
Presented by Carl Zeiss Meditec, Inc.
The Evolution of Stroke Treatment and Future Directions
Faculty: Erol Veznedaroglu, MD, FAANS
Acute ischemic stroke and treatment of patients presenting more than six hours after onset of symptoms.
Presented by Stryker